투자판단관련주요경영사항(임상시험계획승인신청) (동종 연골세포 스페로이드(스페로큐어)의 제1/2a상 임상시험계획 승인신청)[코]
바이오솔루션· 086820 More filings
Received: 11/10/2025 · Reporter: 바이오솔루션
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 20 filings
- Same category
- 15 filings
- Previous same-category filing
- 7/14/2026
- Corrections / withdrawals
- 0 filings
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).